Wisconsin Right to Life: Responds to FDA approval of generic abortion drug 

This week the FDA announced approval of a generic version of the abortion drug mifepristone. The manufacturer of this generic drug openly states that their drug is designed to “terminate a pregnancy” and that their mission is to “normalize abortion.”  Over the past several years, the FDA has steadily weakened critical safety protocols for mifepristone — such as requiring in-per...